Health News Roundup: Ebola kills doctor in Uganda, first health worker killed in latest outbreak; Amylyx prices newly approved ALS drug at $158,000 per year and more

"I regret to announce that we have lost our first doctor, Dr. Mohammed Ali, a Tanzanian national, 37-year-old Male," the health minister, Jane Ruth Aceng, tweeted. Moderna refused China request to reveal vaccine technology - FT Moderna Inc has refused to hand over to China the core intellectual property behind the development of its COVID-19 vaccine, leading to a collapse in negotiations on its sale there, the Financial Times reported on Saturday, citing people familiar with the matter.


Devdiscourse News Desk | Updated: 03-10-2022 02:47 IST | Created: 03-10-2022 02:28 IST
Health News Roundup: Ebola kills doctor in Uganda, first health worker killed in latest outbreak; Amylyx prices newly approved ALS drug at $158,000 per year and more
Representative image Image Credit: Twitter(@GovernmentZA)

Following is a summary of current health news briefs.

Ebola kills doctor in Uganda, first health worker killed in latest outbreak

A Tanzanian doctor working in Uganda who contracted Ebola has died, the first health worker killed by the disease in the latest outbreak in the country, Uganda's health minister said on Saturday. "I regret to announce that we have lost our first doctor, Dr. Mohammed Ali, a Tanzanian national, 37-year-old Male," the health minister, Jane Ruth Aceng, tweeted.

Moderna refused China request to reveal vaccine technology - FT

Moderna Inc has refused to hand over to China the core intellectual property behind the development of its COVID-19 vaccine, leading to a collapse in negotiations on its sale there, the Financial Times reported on Saturday, citing people familiar with the matter. The Cambridge, Massachusetts-based pharmaceutical company turned down China's request to hand over the recipe for its mRNA vaccine because of commercial and safety concerns, the newspaper said, citing people involved in negotiations that took place between 2020 and 2021, adding that the vaccine maker is still "eager" to sell the product to China.

Amylyx prices newly approved ALS drug at $158,000 per year

Amylyx Pharmaceuticals Inc on Friday set the list price of its newly approved drug to treat amyotrophic lateral sclerosis (ALS) at about $158,000 per year in the United States, a discount to its most recently approved competitor. The drug Relyvrio was approved by the U.S. Food and Drug Administration on Thursday, making it the third ALS treatment to get the regulator's nod after Japanese firm Mitsubishi Tanabe's Radicava, priced at around $170,000 per year, and the generic drug riluzole.

Cholera kills at least seven in Haiti as disease returns

Haiti on Sunday said at least seven people have died of cholera in a surprise return of the disease that comes as the nation is paralyzed by a gang blockade that has triggered shortages of fuel and clean drinking water. The disease killed some 10,000 people through a 2010 outbreak that has been blamed on a United Nations peacekeeping force. The Pan American Health Organization in 2020 said Haiti had gone a year with no confirmed cholera cases.

(With inputs from agencies.)

Give Feedback